Using DNA to delete disease

DNA is obscured by closed chromatin, an innately protective structure made up of proteins that interact with each other and with DNA. New activation associated proteins (AAPs) can be custom-built to bind near and open up chromatin so that DNA is made more accessible to gene-editing molecules like CRISPR. CREDIT: illustration by Karmella Haynes

Article Highlights

Protein editorial assistants are clearing the way for cut-and-paste DNA editors, like CRISPR, to access previously inaccessible genes of interest. Opening up these areas of the genetic code is critical to improving CRISPR efficiency and moving toward futuristic, genetic-based assaults on disease.
“The innovation in this paper is having another protein co-delivered with the CRISPR DNA editor, moving chromatin packaging out of the way, so CRISPR has greater access to the DNA,” said lead author Karmella Haynes, from Arizona State University and Emory University.
Haynes describes chromatin blocking as “the elephant in the room” in CRISPR discussions, but it wasn’t directly proved until 2016, when Haynes’ team conducted some clever experiments capturing the effect. Her team is trying to fix the problem by investigating different methods of chromatin disruption.
“The idea is that if CRISPR needs to bind in the middle of a gene but can’t bind close enough to edit the mutation, you could send in our chromatin-opening protein to right outside that hard-to-bind region, rearrange the chromatin, and make the DNA across that gene more accessible for CRISPR to edit the gene,” explained Haynes, who is keen for others to use her system to improve CRISPR efficiency. She pointed out the AAPs can be adapted to target different genes, simply by switching the DNA-binding regions.

The Complete Story: Opening Up DNA to Delete Disease

Arizona State University | Emory University | University of Utah

Go deeper with Bing News on:

Deleting disease

Myelin renewal reverses AD cognitive dysfunction in mice
on June 11, 2021 at 7:24 am
Researchers have demonstrated that enhancing myelin renewal in the brains of transgenic APP/PS1 mouse models of Alzheimer's disease (AD) can improve their task-related hippocampal activity.
How Fanatics Took Over the World
on June 10, 2021 at 12:25 pm
As with most every revolution in history, a small minority of crazy people with a cause prevailed over the humane rationality of ...
Guidelines for black fungus disease management in children below 18 years issued
on June 10, 2021 at 12:33 am
`Do not wait for culture results to initiate therapy as mucormycosis is an emergency. Early complete surgical debridement is the cornerstone of treatment, and maybe repeated as required,` the DGHC sai ...
Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate
on June 9, 2021 at 10:05 pm
Phase 3 trial VLA1553-302 and will be followed for a total of six months. The objective of the trial is to show manufacturing consistency of the vaccine by demonstrating that three consecutively ...
Fauci-funded scientist: ‘Chinese colleagues’ created ‘killer’ coronavirus
on June 9, 2021 at 7:31 am
Fauci-Funded Daszak Describes 'Colleagues In China' Manipulating Viruses Into 'Killers' In his remarks to the panel in 2016, Daszak describes the Wuhan lab’s work of “insert [ing] spike proteins” into ...

Go deeper with Google Headlines on:

Deleting disease

Grant Backs CRISPR Therapy Research for Familial ALS - ALS News Today
May 28, 2021
Army Grant Assists Researchers' Mission Against ALS - University of Texas at Dallas
May 21, 2021
Deleting rare autism gene leads to physical, social differences in mice - Spectrum
June 3, 2021
People Are Ready To Log Off Social Media For Good - BuzzFeed News
May 20, 2021
Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate - BioSpace
June 10, 2021

Go deeper with Bing News on:

Protein editorial assistants

UMass Researchers Create ‘Green’ Electronic Microsystems
on June 11, 2021 at 3:56 pm
A research team from the University of Massachusetts Amherst has developed an electronic microsystem that can intelligently, autonomously respond to information inputs without external energy. The ...
FDA Extends Approval of TRIKAFTA For Cystic Fibrosis
on June 10, 2021 at 8:30 pm
Cystic fibrosis is caused by a defective protein that is the result of mutations in the CFTR gene. Although there is approximately 2,000 known cystic fibrosis transmembrane conductance ...
Changing Rapamycin Target Protein Causes Autophagy
on June 4, 2021 at 5:40 am
Targeting the protein called FK506-binding protein 51 ... blood brain barrier is significant," said Bailus, who is now an Assistant Professor of Genetics at the Keck Graduate Institute in ...
Food scientists aim to make plant-based protein tastier and healthier
on June 3, 2021 at 4:59 pm
Co-author Lutz Grossmann, who recently joined the UMass Amherst food science team as an assistant professor, has expertise in alternative protein sources, McClements notes. "Our research has ...
High-Protein Diet Linked to Greater Glucose Stability in Type 1
on June 3, 2021 at 1:01 pm
In a recent study, reducing carbohydrate and increasing protein in the diet had short-term benefits for type 1 diabetes.